Advertisement
iShares Genomics Immunology and Healthcare ETF

iShares Genomics Immunology and Healthcare ETF (IDNA) Stock Competitors & Peer Comparison

See (IDNA) competitors and their performances in Stock Market.

IDNAAMEX
Financial ServicesAsset Management
$30.56
$0.17(0.56%)
U.S. Market opens in 29h 8m
Advertisement

Peer Comparison Table: Asset Management Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IDNA$30.56+0.56%164.7M19.64$1.56+0.92%
VSMPX$337.97+1.14%2.3T26.36$12.82N/A
VTSAX$180.13+1.14%2.3T26.36$6.83+1.01%
VITSX$180.16+1.14%2.3T26.36$6.84N/A
PMFLX$10.16+0.20%2TN/AN/AN/A
VFIAX$693.94+1.09%1.7T26.88$25.82N/A
VFINX$693.94+1.09%1.7T26.87$25.82N/A
VFFSX$367.96+1.09%1.7T26.88$13.69N/A
FXAIX$261.21+1.09%841.2BN/AN/AN/A
VTSNX$186.39+0.89%658.1B18.19$10.25N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IDNA vs VSMPX Comparison June 2026

IDNA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IDNA stands at 164.7M. In comparison, VSMPX has a market cap of 2.3T. Regarding current trading prices, IDNA is priced at $30.56, while VSMPX trades at $337.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IDNA currently has a P/E ratio of 19.64, whereas VSMPX's P/E ratio is 26.36. In terms of profitability, IDNA's ROE is +0.00%, compared to VSMPX's ROE of N/A. Regarding short-term risk, IDNA is more volatile compared to VSMPX. This indicates potentially higher risk in terms of short-term price fluctuations for IDNA.Check VSMPX's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions